Evaxion A EVAX
NASDAQ EVAX
$3.31 +0.03 (+0.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025)

Evaxion A's (EVAX) quarterly Other Accumulated Expenses came in at $1.2 million in Q2 2025, up 56.5% YoY from $738000.0 in Q2 2024, and up 24.6% on a QoQ basis from $927000.0 in Q4 2024.

Evaxion A (EVAX) Other Accumulated Expenses (2020 - 2025) Analysis & Trends

Evaxion A (EVAX) has 6 years of Other Accumulated Expenses data on file, last reported at $1.2 million in Q2 2025.

  • Quarterly Other Accumulated Expenses rose 56.5% year-over-year to $1.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1.2 million (up 56.5% YoY) and the FY2024 annual result came in at $927000.0, down 7.85% from the prior year.
  • Other Accumulated Expenses advanced to $1.2 million in Q2 2025, from $927000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $3.1 million in Q2 2021 to a low of $665000.0 in Q4 2022.
  • A 5-year average of $1.4 million and a median of $1.0 million in 2021 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2022 — Other Accumulated Expenses slumped 70.86% — and 2023, when it surged 60.02%.
  • Tracing EVAX's Other Accumulated Expenses over 5 years: stood at $1.0 million in 2021, then sank by 35.75% to $665000.0 in 2022, then soared by 51.28% to $1.0 million in 2023, then declined by 7.85% to $927000.0 in 2024, then grew by 24.6% to $1.2 million in 2025.
  • The last three Other Accumulated Expenses figures came in at $1.2 million (Q2 2025), $927000.0 (Q4 2024), and $738000.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Evaxion A 27.61 Mn 27.61 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 1.16 Mn
Dec 31, 2024 927,000.00
Jun 30, 2024 738,000.00
Dec 31, 2023 1.01 Mn
Jun 30, 2023 1.49 Mn
Dec 31, 2022 665,000.00
Jun 30, 2022 933,000.00
Mar 31, 2022 744,000.00
Dec 31, 2021 1.04 Mn
Sep 30, 2021 2.91 Mn
Jun 30, 2021 3.11 Mn
Mar 31, 2021 2.55 Mn
Dec 31, 2020 2.26 Mn